Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(FY)Nov 30, 2023 | (FY)Nov 30, 2022 | (FY)Nov 30, 2021 | (FY)Nov 30, 2020 | (FY)Nov 30, 2019 | (FY)Nov 30, 2018 | (FY)Nov 30, 2017 | |
---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | |||||||
Cash from operating activities | 435.13%120.73M | -133.99%-36.03M | 0.78%105.98M | -64.53%105.16M | 237.79%296.49M | 885.11%87.77M | 8.91M |
Net profit before non-cash adjustment | 131.35%75.68M | -476.99%-241.42M | -65.88%64.04M | -25.42%187.68M | 341.99%251.65M | 354.50%56.94M | --12.53M |
Total adjustment of non-cash items | -13.48%142.66M | 122.51%164.89M | 12.66%74.11M | -20.83%65.78M | 7.44%83.09M | 1.59%77.34M | --76.13M |
-Depreciation and amortization | 48.09%138M | 28.59%93.19M | 20.90%72.46M | 9.25%59.94M | 26.33%54.86M | -17.77%43.43M | --52.81M |
-Reversal of impairment losses recognized in profit and loss | -59.74%20.26M | 1,431.81%50.32M | -67.15%3.29M | 872.76%10M | --1.03M | ---- | ---- |
-Disposal profit | -170.10%-25.33M | 66.59%-9.38M | -15,273.51%-28.07M | -80.55%185K | -80.76%951K | 163.04%4.94M | ---7.84M |
-Remuneration paid in stock | 102.00%2.52M | --1.25M | --0 | ---- | ---- | ---- | ---- |
-Other non-cash items | -75.57%7.21M | 11.69%29.52M | 708.38%26.43M | -116.55%-4.34M | -9.37%26.25M | -7.04%28.96M | --31.16M |
Changes in working capital | -341.00%-97.61M | 225.91%40.5M | 78.31%-32.17M | -287.60%-148.29M | 17.72%-38.26M | 41.70%-46.5M | ---79.75M |
-Change in receivables | 23.70%-71.08M | -14.13%-93.15M | -125.19%-81.62M | 63.10%-36.24M | 5.08%-98.23M | -7.02%-103.49M | ---96.7M |
-Change in inventory | 83.06%-217K | 53.30%-1.28M | -416.01%-2.74M | 168.94%868K | -197.64%-1.26M | -220.86%-423K | --350K |
-Change in payables | -53.39%9.19M | 32.50%19.72M | 145.61%14.88M | -253.99%-32.63M | 173.33%21.19M | 148.41%7.75M | --3.12M |
-Provision for loans, leases and other losses | -92.53%662K | 157.26%8.86M | 140.06%3.44M | -311.34%-8.6M | -120.47%-2.09M | 162.47%10.21M | --3.89M |
-Changes in other current assets | -131.54%-21.03M | 5,985.08%66.68M | 98.26%-1.13M | -195.41%-65.24M | -120.57%-22.09M | -4,737.20%-10.01M | ---207K |
-Changes in other current liabilities | -138.16%-15.14M | 13.36%39.67M | 643.11%35M | -110.04%-6.44M | 29.82%64.21M | 404.91%49.46M | --9.8M |
Dividends paid (cash flow from operating activities) | |||||||
Dividends received (cash flow from operating activities) | |||||||
Interest paid (cash flow from operating activities) | -14.63%-11.08M | 3.64%-9.67M | 13.35%-10.03M | -9.48%-11.58M | 8.47%-10.58M | -2.95%-11.55M | -11.22M |
Interest received (cash flow from operating activities) | 223.30%333K | 296.15%103K | -16.13%26K | -13.89%31K | -94.71%36K | -70.43%681K | 2.3M |
Tax refund paid | 79.00%-11.99M | 47.27%-57.1M | -27.05%-108.3M | -422.88%-85.24M | -132.85%-16.3M | 81.29%-7M | -37.41M |
Other operating cash inflow (outflow) | 0.00%-1K | -1K | 0 | 0.00%-1K | 0.00%-1K | -1K | 0 |
Operating cash flow | 195.43%97.99M | -733.52%-102.69M | -247.12%-12.32M | -96.89%8.37M | 285.76%269.64M | 286.79%69.9M | ---37.42M |
Investing cash flow | |||||||
Net PPE purchase and sale | 90.42%-48.71M | 14.88%-508.26M | -265.86%-597.1M | -86.03%-163.2M | -1.79%-87.73M | -99.64%-86.19M | ---43.17M |
Net intangibles purchase and sale | --0 | 91.45%-3.05M | ---35.68M | ---- | 90.82%-425K | 63.17%-4.63M | ---12.57M |
Net business purchase and sale | 93.47%-23.91M | ---365.96M | --0 | ---16.6M | ---- | -73.05%-43.52M | ---25.15M |
Net investment product transactions | ---- | ---- | ---- | --88.17M | ---- | -86.68%1.47M | --11.06M |
Advance cash and loans provided to other parties | -90.00%-19M | ---10M | --0 | ---- | ---- | 99.82%-54K | ---29.4M |
Repayment of advance payments to other parties and cash income from loans | 703.68%6.99M | --870K | ---- | 129.18%2.22M | -97.19%970K | 487.76%34.56M | --5.88M |
Net changes in other investments | 58.09%-9.51M | 39.21%-22.68M | -720.70%-37.31M | 85.39%-4.55M | 16.18%-31.11M | -170.70%-37.12M | ---13.71M |
Investing cash flow | 89.65%-94.13M | -35.67%-909.08M | -613.16%-670.09M | 20.57%-93.96M | 12.68%-118.3M | -26.54%-135.47M | ---107.06M |
Financing cash flow | |||||||
Net issuance payments of debt | -101.86%-10.94M | -35.68%587.48M | 21.65%913.33M | 349.70%750.81M | 1,277.33%166.96M | -95.93%12.12M | --297.53M |
Net common stock issuance | -72.36%393K | 105.63%1.42M | -102.59%-25.25M | --974.64M | ---- | ---- | --5.44M |
Increase or decrease of lease financing | 34.03%-4.53M | 20.08%-6.87M | -2.04%-8.6M | -2.16%-8.43M | -64.35%-8.25M | -177.54%-5.02M | ---1.81M |
Issuance fees | ---- | ---- | ---- | ---7.62M | ---- | ---- | ---- |
Net other fund-raising expenses | ---- | ---- | 99.67%-1K | -14,950.00%-301K | -100.00%-2K | 100.00%-1K | ---20M |
Financing cash flow | -102.59%-15.08M | -33.82%582.03M | -48.54%879.48M | 976.87%1.71B | 2,134.42%158.71M | -97.47%7.1M | --281.16M |
Net cash flow | |||||||
Beginning cash position | -17.27%2.06B | 8.60%2.49B | 243.12%2.29B | 86.68%667.77M | -14.05%357.71M | 48.90%416.18M | --279.51M |
Current changes in cash | 97.39%-11.22M | -318.07%-429.74M | -87.86%197.07M | 423.61%1.62B | 630.29%310.06M | -142.78%-58.47M | --136.68M |
Cash adjustments other than cash changes | ---1K | ---- | -200.00%-1K | 0.00%1K | 200.00%1K | ---1K | ---- |
End cash Position | -0.55%2.05B | -17.27%2.06B | 8.60%2.49B | 243.12%2.29B | 86.68%667.77M | -14.05%357.71M | --416.18M |
Free cash flow | 64.01%-266.11M | 18.39%-739.47M | -470.22%-906.14M | -187.58%-158.91M | 751.94%181.45M | 78.09%-27.83M | ---127.06M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |